Everlife

Everlife

Signal active

Investment Firm

Overview

Everlife Asia is a buy-and-build platform aimed to provide complete solutions for the healthcare and research industries.

Highlights

Founded

2014

Industry

Health Care

Employees

501-1000

Investment

2

Lead Investment

2

Exits

undefined

Stages

Early Stage Venture

Investor Type

N/A

Location

Asia

Contact Information

Social

Profile Resume

Everlife, established in 2014 and headquartered in Asia., specializes in Early Stage Venture investments across Biotechnology, Oncology, Education, Health Care, Product Research, Commercial, Information Technology, Consulting, Pharmaceutical, Medical. Their recent investments include AUM Biosciences, The Agency for Science, Technology and Research, SPRIM, CPC Diagnostics. The highest investment round they participated in was $2.3B. Among their most notable exits are AUM Biosciences and The Agency for Science, Technology and Research. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Raman Gandotra

Raman Gandotra

Group Chief Executive Officer

Investment portfolio

Everlife has made 2 investments. Their most recent investment was on Oct 12, 2021, when AUM Biosciences raised $27.0M.

investments

2

Diversity investments

0

Lead investments

2

Number of exits

undefined

Investments

2

Annouced DateOrganization NameIndustryMoney Raised
Mar 14, 2019
CPC Diagnostics CPC Diagnostics
Health Carenull
Oct 12, 2021
AUM Biosciences AUM Biosciences
Biotechnology27.0M

Exits

0

Funding Timeline

Funding rounds

2

Investors

1

Funds

0

Funding Rounds

2

Everlife has raised 2 rounds. Their latest funding was raised on Oct 12, 2021 from a Series A - AUM Biosciences round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Mar 14, 2019
Corporate Round - CPC Diagnostics Corporate Round - CPC Diagnostics
-0-
Oct 12, 2021
Series A - AUM Biosciences Series A - AUM Biosciences
-27.0M-

Investors

1

Everlife is funded by 1 investor(s). HBM Healthcare Investments Kantor is the most recent investors.

Investor NameLead InvestorFunding RoundMoney Raised
HBM Healthcare Investments HBM Healthcare Investments
No
Series A - Everlife
0

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.